Zim Laboratories Limited
Tata Mutual Fund increased its stake in Zim Laboratories from 1.07% to 1.18%, purchasing 59,564 shares.
A pharmaceutical manufacturer established in 1989, Zim Laboratories specializes in producing formulation drugs and pre-formulation ingredients for both domestic and international markets. The company operates manufacturing facilities across India with capabilities in drug development, quality assurance, and distribution. It serves healthcare providers and patients through a diversified portfolio of therapeutic formulations marketed within India and exported to markets worldwide.
AMC subsidiary of the Tata Group, India's most diversified conglomerate. Manages over Rs 1.8 lakh crore with a wide range of equity, debt and hybrid schemes. Part of the broader Tata Capital financial services ecosystem. Tata Small Cap Fund and Tata Digital India Fund have been among the most popular thematic and segment-specific equity offerings.